30 There was a strong trend of reduction, although not statistically significant, in mortality or first CHF hospitalization among patients who were treated with ACE-I or ARB (HR 0.63; 95% CI 0.31–1.07), and a statistically significant 42% reduction among patients treated with BBs (HR 0.58; 95% CI 0.34–0.79).
← all excerpts
A comprehensive review of chronic heart failure pharmacotherapy treatment approaches in African Americans.
1
—
—